Providing services to benefit the Pharmacy profession

Facebook Twitter

Pharmacy Connect is conducting our 1st survey of pharmacy professional salaries to determine whether pharmacy professionals are sufficiently well paid for the important work that they do. We would like you to be part of this survey, which contains only 5 questions and is completely anonymous, and will take no more than 3 minutes to complete. To start the survey, click on this link: http://www.surveymonkey.com/s/HF2WSFK

 

Announced at this week’s international AIDS Vaccine Conference in Barcelona, the South African trial will involve the only vaccine shown to have some effect on the virus when it was tested among 16,000 people in Thailand. Released in 2009, the Thai trial’s results showed that HIV infection rates were 31 percent lower in participants who had received the vaccine than those who had not.

http://www.health-e.org.za/2013/10/09/sa-offers-hiv-vaccine-research-hope

 

Fraudulent scripts – Gauteng area (Message from PSSA): The PSSA has been contacted by MacRobert Attorneys regarding fraudulent prescriptions on a letterhead of Drs Kilian, Nienaber, Williams & associates. They requested that the PSSA inform all members in the Gauteng area of the problem. It seems that a person has produced a fake prescription pad and now uses the fake letterheads to prescribe Ivedal® sleeping tablets (contains Zolpidem tartrate). The dose is always 2 tablets nocte (60 tabs) and repeated for 6 months. The patient name used is a fake name, and is a different name every time. The prescriptions have been presented to various pharmacies in Pretoria and even the Springs area. The prescriptions are always paid for in cash and never claimed from a medical aid. … A copy of the letter from MacRobert’s, the correct prescription letterhead and an example of the fake prescriptions have been uploaded on the PSSA website (http://www.pssa.org.za/E_News.asp). Zolpidem tartrate use Members are reminded that Zolpidem tartrate tablets are only registered with the MCC for short term treatment of insomnia in adults when the insomnia is severe or disabling or if the patient is under severe stress. The maximum treatment period is 4 weeks including the tapering-off period. Prescriptions of schedule 5 medication The Medicines Control Act (Act 101 of 1965) clearly states in Section 22A(6) the following: (h)  Where a Schedule 5 substance is used for— (i)    its anxiolytic, anti-depressant or tranquillising properties it shall not be prescribed for longer than six months unless the authorised prescriber has consulted a registered psychiatrist, or, in the case of a psychiatrist, another psychiatrist before issuing a new prescription; (ii)    its analgesic properties it shall not be prescribed for longer than six months unless the authorised prescriber has consulted another medical practitioner, before issuing a new prescription

Proudly powered by WordPress